UPC APP 68623/2024

—·EP4201327: FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Insulet Corporation
Vertreter: Marc Grunwald (Peterreins Schley); Frank Peterreins (Peterreins Schley)
Beklagte
A. Menarini Diagnostics s.r.l.
Vertreter: Christopher Maierhöfer (Bird & Bird LLP); Jonathan Hechler (Bird & Bird LLP)
Division: Court of Appeal
Richter: Patricia Rombach · Legally Qualified Judge / Judge-Rapporteur
Technology: Packaging & Conveying
Sprache: —
Erste Entscheidung: 9. Jan. 2025

Entscheidungen

2025-01-09
Generic application
Order by the Court of Appeal (UPC_CoA_769/2024, 9 January 2025) confirming that Menarini benefited from an automatic extension of the deadline for lodging its statement of response under R. 301.2 RoP because a CMS technical malfunction prevented filing around the 27 December 2024 deadline. The extension runs until the end of the first working day after the system became accessible again.
Rechtsfragen:Automatic extension of time due to CMS technical failure (R. 301.2 RoP)

Dokumente